The Henry M. Jackson Foundation for the Advancement of Military Medicine

Advancing Military Medicine

Search Results - assay

3 Results Sort By:
Assays and Reagents for the Detection of Soluble gp120 (HJF 651-23)
Researchers at the University of Montreal affiliated hospital research centre (CRCHUM) and the Uniformed Services University of the Health Sciences (USU) have developed an ELISA-based assay to detect soluble HIV gp120 in human biological fluids with pg/mL sensitivity, high reproducibility, and specificity. Applications and Advantages Highly sensitive,...
Published: 6/11/2026   |   Updated: 6/11/2026   |   Inventor(s): Marzena Pazgier, Andres Finzi, Jonathan Richard, Benlarbi Mehdi
Keywords(s): Assay, Biomarker, Fostemsavir, gp120
Category(s): Diagnostic
Diagnostic Tool for High-grade Serous Ovarian Cancer - (HJF 616-21)
Researchers at HJF, Inova Fairfax Hospital (IFH), and the Peter MacCallum Cancer Centre (PMCC) have identified orthogonal protein and transcript-based biomarkers correlating with Homologous Recombination Deficiency (HRD). This may lead to a companion clinical diagnostic assay to prioritize High-Grade Serous Ovarian Cancer (HGSOC) patients for targeted...
Published: 7/1/2026   |   Updated: 12/12/2024   |   Inventor(s): Nicholas Bateman, Tamara Abulez, Thomas Conrads, George Larry Maxwell, Dale Garsed, David Bowtell, Ahwan Pandey
Keywords(s): Assay, Biomarker Assay, Companion Diagnostic, DDR, DNA Damage Repair, HGSOC, High-Grade Serous Ovarian Carcinoma, Ovarian Cancer, PARP Inhibitors
Category(s): Therapeutic, Diagnostic
Immunogens and Vaccine Components Against HIV - (HJF 630-22)
Henry M. Jackson Foundation (HJF) and Walter Reed Army Institute of Research (WRAIR) researchers have developed a novel vaccine strategy against HIV-1. These vaccine candidates are designed to elicit broadly neutralizing antibodies that could protect against a wide variety of HIV strains. Applications and Advantages Novel vaccine design approach...
Published: 7/1/2026   |   Updated: 2/12/2024   |   Inventor(s): Morgane Rolland, Eric Lewitus, Hongjun Bai, Shelly Krebs
Keywords(s): Antibodies, Assay, bnAbs, CD4, Env, HIV, Vaccines
Category(s): Therapeutic